Dyspepsia
Dyspepsia
Dyspepsia
Isaga, Pacelen T.
Dyspepsia chronic or recurrent pain or discomfort centered in the upper abdomen Discomfort includes mild pain, upper abdominal fullness and feeling full earlier than expected with eating
Dyspepsia
=accompanied by bloating, belching, nausea or heartburn =may be called indigestion
Classification
Dyspepsia has been proposed to have symptomatic subgroups: ulcerlike - "Pain centered in the upper abdomen is the predominant (most bothersome) symptom. dysmotilitylike - "An unpleasant or troublesome nonpainful sensation (discomfort) centered in the upper abdomen is the predominant symptom; this sensation may be characterized by or associated with upper abdominal fullness, early satiety, bloating, or nausea." refluxlike-heart burn and acid regurgitation nonspecific
Cause/etiology
Some cases are caused by medications calcium antagonists, nitrates, theophyllines, bisphosphonates, corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs) Several studies provide prevalences of underlying causes based on findings at esophagogastroduodenoscopy (EGD)
Management Recommendations
Patients 55 years of age or younger without alarm features =should receive H pylori test and treat followed by acid suppression if symptoms remain =H pylori testing is optimally performed by a C-urea breath test or stool antigen test =PPIs are the drug class of choice for acid suppression
Patients older than 55 years of age and for younger patients with alarm features (ex, weight loss, progressive dysphagia, recurrent vomiting, evidence of gastrointestinal bleeding, or family history of cancer) presenting with new-onset dyspepsia =Biopsy specimens should be obtained for H pylori at the time of endoscopy and eradication therapy offered to those who are infected because this may reduce the risk of subsequent peptic ulcer disease and gastric malignancy
Treatment
Antacids and alginates =relieve and prevent symptoms of dyspepsia =effectively reduce acid but evidence of healing effect has not been demonstrated
H. pylori infection =One week triple therapy regimens including PPI, amoxicillin, and either clarithromycin or metronidazole to eradicate H.pylori in 90% of cases. =ranitidine bismuth citrate (H2 Receptor Antagonist) sometimes used instead of PPI
H2 Receptor Antagonist =reduces gastric acid output promoting ulcer healing and relieving gastro esophageal reflux symptoms Prostaglandin analogues =reduces acid secretion and protects the gastric and duodenal linings, and promoting ulcer healing
Proton pump inhibitor =treat gastric and duodenal ulcers, GERD, and esophagitis and to prevent and treat NSAID associated ulcers and are used together with antibacterials to eradicate H. pylori